Metal-Ligand-Anion Cooperation in C-H Bond Formation at Platinum(II).

Thermolysis of [(BPI)Pt(CH)][OTf] (BPI = 1,3-bis(2-(4--butyl)pyridylimino)isoindole) to release methane and form (BPI)Pt(OTf) is reported. Kinetic, mechanistic, and computational studies point to an unusual anion-assisted pathway that obviates the need for a higher oxidation state intermediate to couple the metal-bound methyl group with the ligand-bound hydrogen. Leveraging this insight, a triflimide derivative of the (BPI)Pt complex was shown to activate benzene, highlighting the role of the counteranion in controlling the activity of these complexes.

Derivatives of DANPY (Dialkylaminonaphthylpyridinium), a DNA-Binding Fluorophore: Practical Synthesis of Tricyclic 2-Amino-6-bromonaphthalenes by Bucherer Reaction.

A simple and convergent way to synthesize 2-amino-6-bromonaphthalenes involves condensation of free secondary amines with the corresponding 2-naphthol under Bucherer conditions. The amination protocol relies on common Teflon-capped pressure flasks and has been used to modify the tertiary aminonaphthalene core of DANPY, a biocompatible chromophore shown to be safe and effective for staining a variety of cellular targets. Following a Suzuki reaction with pyridine 4-boronic acid, additional diversity is introduced upon -alkylation to install the pyridinium cation.

The role of variant alleles of the mannose-binding lectin in the inhibitor development in severe hemophilia A.

Introduction: The administration of FVIII leads to inhibitors in up to 30% of patients with hemophilia A (HA), the most severe treatment complication. FVIII-mannosylation fosters the presentation of FVIII to CD4-T-lymphocytes. Mannose as primary ligand for the mannose-binding lectin (MBL) activates the lectin pathway of complement.

Salicylate-based phytopharmaceuticals induce adaptive cytokine and chemokine network responses in human fibroblast cultures.

Background: Cytokines and chemokines (CC) play a central role in immunoregulatory and inflammatory processes. Neutralising antibodies for single proinflammatory cytokines have developed into a powerful, though expensive and not always curative therapeutic strategy for severe diseases. Considering the redundancy of CC functions, network (N) rather than single target approaches are essential.